Emily Capone
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 22
- HER2/EGFR in Cancer Research 13
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Gianluca SalaStefano IacobelliVincenzo De LaurenziRodolfo IppolitiFrancesco GiansantiRossano LattanzioAnnamaria CiminiRoberta Gentile
- Journals
- Oncotarget (3 papers)Journal of Controlled Release (3 papers)Cancer Research (3 papers)Oncogenesis (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ItalyUnited KingdomAustralia
In The Last Decade
Emily Capone
35 papers receiving 719 citations
Peers
Comparison fields: 5 of 76
- Oncology 396
- Radiology, Nuclear Medicine and Imaging 223
- Cancer Research 105
- Immunology 143
- Molecular Biology 352
Countries citing papers authored by Emily Capone
This map shows the geographic impact of Emily Capone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Capone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Capone more than expected).
Fields of papers citing papers by Emily Capone
This network shows the impact of papers produced by Emily Capone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Capone. The network helps show where Emily Capone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emily Capone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 89 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 17 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 125 | |
| 17 | 2019 | 8 | |
| 18 | 2018 | 32 | |
| 19 | 2018 | 28 | |
| 20 | 2015 | 73 |
About Emily Capone
Emily Capone is a scholar working on Oncology, General Dentistry, Neurology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 36 papers that have together received 723 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Neuroblastoma Research and Treatments (7 papers), Glycosylation and Glycoproteins Research (5 papers), Galectins and Cancer Biology (5 papers), Extracellular vesicles in disease (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Oncology (396 citations), Radiology, Nuclear Medicine and Imaging (223 citations), Cancer Research (105 citations), Immunology (143 citations) and Molecular Biology (352 citations). Emily Capone has collaborated with scholars based in Italy, United Kingdom and Australia. Frequent co-authors include Gianluca Sala, Stefano Iacobelli, Vincenzo De Laurenzi, Rodolfo Ippoliti, Francesco Giansanti, Rossano Lattanzio, Annamaria Cimini, Roberta Gentile, Cosmo Rossi and Daniela D’Agostino. Their work appears in journals such as Oncotarget, Journal of Controlled Release, Cancer Research, Oncogenesis and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.